News

Search:

In Landmark Ruling, Court Sees Off-Label Marketing as Protected Free Speech

1 Likes

In a potentially landmark ruling, the US 2nd Circuit Court of Appeals has reversed a lower court's finding that a pharmaceutical sales representative was guilty of promoting off-label uses for certain Read More...

Tags:

Court

Decision

Landmark

marketing

Off Label

Off-Label

Promotion

Sales

Sorrell v IMS

Indian Drug Representatives Strike for Strengthened Regulations

0 Likes

More than 150,000 sales representatives for pharmaceutical companies went on strike on 23 August in the hopes of spurring greater regulation of their industry in an attempt to reduce corruption and Read More...

Tags:

drug

ethics

FMRAI

India

Pharmaceutical

Representatives

Reps

Sales

Strike

FDA Wants More Data on Antibiotics

0 Likes

The US Food and Drug Administration (FDA) has released an advanced notice of proposed rulemaking—the precursor process for promulgating a regulation—saying it wants to reassess the information Read More...

Tags:

ADUFA

Animal

Data

Distribution

FDA

NARMS

Sales

Veterinary

J&J Announces Planned Cessation of Vaginal Mesh Sales

0 Likes

Johnson & Johnson subsidiary Ethicon announced on 5 June 2012 it will cease sales of a controversial line of vaginal mesh implant products after being hit with a series of lawsuits alleging the Read More...

Tags:

Ethicon

FDA

J&J

Johnson & Johnson

Lawsuits

Regulatory Approval

Sales

Unapproved

Vaginal Mesh

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

In Landmark Ruling, Court Sees Off-Label Marketing as Protected Free Speech

Indian Drug Representatives Strike for Strengthened Regulations

FDA Wants More Data on Antibiotics

J&J Announces Planned Cessation of Vaginal Mesh Sales

Get RF Today